York firm signs exclusive weight loss deal in Singapore

OptiBiotix Health, which develops compounds to tackle obesity, high cholesterol and diabetes, has signed an exclusive distribution agreement for SlimBiome Medical with United Italian Trading Corporation.

SlimBiome is an ingredient to support weight loss and weight management

The agreement gives the firm exclusive rights to distribute OptiBiotix’s SlimBiome Medical proprietary weight management product in Singapore. SlimBiome is an ingredient to support weight loss and weight management.

York-based OptiBiotix recently launched a branded SlimBiome product range with Holland & Barrett, the first agreement with a major retailer to market its weight management technology.

Sign up to our Business newsletter

Sign up to our Business newsletter

OptiBiotix said United Italian Trading Corporation (UITC) is an established pharmaceutical company founded in Singapore in 1963.

It distributes pharmaceutical and medical products to a wide variety of clients that include hospitals, polyclinics, medical specialists clinics, family physician clinics, pharmacies, supermarkets and departmental stores.

OptiBiotix added that its core strength is an ability to introduce proven innovative products into the market by working with key opinion leaders, organising user experience clinical trials and selling into major hospitals and clinics.

Exclusivity is subject to the Singapore firm placing a first order of SlimBiome Medical by the end of November for a minimum quantity of 3,000 boxes and increasing annual sales targets.

The new agreement builds on the award OptiBiotix won for SlimBiome Medical in Singapore in 2019 for the best weight management product of the year for Asia.

Dr Fred Narbel, managing director of OptiBiotix’s prebiotics division, said: “We are pleased to have signed an agreement with UITC to distribute our award-winning medical device in Singapore.

"UITC contacted us expressing an interest in our CE-marked medical device after carefully reviewing our peer-reviewed publications underlining the recognition and reputation OptiBiotix is establishing globally for its brands and scientific work.”

Dexter Fung, deputy managing director at UITC, added: “As an established pharmaceutical company, our vision is to distribute products that meet the needs of consumers to achieve and maintain optimal quality of life.

"Obesity is on the rise in Singapore, increasing the risk of developing health problems like diabetes, heart disease and stroke.

"UITC feels that the award winning SlimBiome Medical has great potential to fill the void of an effective weight control product in helping people to lose weight safely and effectively. In the last two decades, several weight loss medications and supplements have been withdrawn due to safety issues, we feel strongly that SlimBiome Medical is the answer to this need.”